AT297731B - Verfahren zur Herstellung von neuen Guanylhydrazonen und ihren Salzen - Google Patents

Verfahren zur Herstellung von neuen Guanylhydrazonen und ihren Salzen

Info

Publication number
AT297731B
AT297731B AT343970A AT343970A AT297731B AT 297731 B AT297731 B AT 297731B AT 343970 A AT343970 A AT 343970A AT 343970 A AT343970 A AT 343970A AT 297731 B AT297731 B AT 297731B
Authority
AT
Austria
Prior art keywords
guanylhydrazones
salts
preparation
new
new guanylhydrazones
Prior art date
Application number
AT343970A
Other languages
English (en)
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH499868A external-priority patent/CH495960A/de
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Application granted granted Critical
Publication of AT297731B publication Critical patent/AT297731B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16Compounds containing any of the groups, e.g. aminoguanidine
    • C07C281/18Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04Derivatives of thiourea
    • C07C335/16Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C335/20Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT343970A 1968-04-04 1969-04-03 Verfahren zur Herstellung von neuen Guanylhydrazonen und ihren Salzen AT297731B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH499868A CH495960A (de) 1968-04-04 1968-04-04 Verfahren zur Herstellung von neuen Guanylhydrazonen
CH268269 1969-02-21

Publications (1)

Publication Number Publication Date
AT297731B true AT297731B (de) 1972-04-10

Family

ID=25691134

Family Applications (2)

Application Number Title Priority Date Filing Date
AT330569A AT291283B (de) 1968-04-04 1969-04-03 Verfahren zur Herstellung von neuen Guanylhydrazonen und ihren Salzen
AT343970A AT297731B (de) 1968-04-04 1969-04-03 Verfahren zur Herstellung von neuen Guanylhydrazonen und ihren Salzen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT330569A AT291283B (de) 1968-04-04 1969-04-03 Verfahren zur Herstellung von neuen Guanylhydrazonen und ihren Salzen

Country Status (9)

Country Link
US (1) US3673241A (de)
AT (2) AT291283B (de)
BE (1) BE731015A (de)
DE (1) DE1914999A1 (de)
FR (1) FR2007382B1 (de)
GB (1) GB1241130A (de)
IE (1) IE33021B1 (de)
NL (1) NL6905258A (de)
SE (1) SE343574B (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1311432A (en) * 1971-01-07 1973-03-28 Ici Ltd Guanidine derivatives their preparation and antiviral compositions containing them
US3917678A (en) * 1972-01-25 1975-11-04 Squibb & Sons Inc Organic acid salts of 1-{8 0-{8 (3-dimethylaminopropyl)thio{9 phenyl{9 -3-methylurea
US5238941A (en) * 1988-03-25 1993-08-24 Ciba-Geigy Corporation Arylhydrazones and pharmaceutical compositions thereof
US4971986A (en) * 1988-03-25 1990-11-20 Ciba-Geigy Corporation Arylhydrazones useful as SAMDC inhibitors
WO2001017953A1 (en) 1999-09-08 2001-03-15 Guilford Pharmaceuticals Inc. Non-peptidic cyclophilin binding compounds and their use
US6656971B2 (en) 2001-01-25 2003-12-02 Guilford Pharmaceuticals Inc. Trisubstituted carbocyclic cyclophilin binding compounds and their use
BRPI0207767B8 (pt) * 2001-02-24 2021-05-25 Boehringer Ingelheim Pharma derivados de xantina, seu uso, composições farmacêuticas, seus processos de preparação, e sais fisiologicamente aceitáveis
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) * 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) * 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
BRPI0711558A2 (pt) 2006-05-04 2011-11-08 Boeringer Ingelheim Internat Gmbh polimorfos
EP1852108A1 (de) * 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG Zusammensetzungen von DPP-IV-Inhibitoren
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
WO2008156573A1 (en) * 2007-06-12 2008-12-24 Provid Pharmaceuticals, Inc. Kinase inhibitors, compositions thereof, and methods of use therewith
EP2190434B1 (de) * 2007-08-17 2019-04-17 Boehringer Ingelheim International GmbH Purin-derivate zur verwendung in der behandlung von erkrankungen im zusammenhang mit fap
PE20091730A1 (es) 2008-04-03 2009-12-10 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
KR20190016601A (ko) 2008-08-06 2019-02-18 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
EP2326326B1 (de) * 2008-08-15 2019-10-09 Boehringer Ingelheim International GmbH Dpp-4 inhibitoren zur verwendung in der wundheilung von diabetes-patienten
RU2011113823A (ru) 2008-09-10 2012-10-20 БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE) Комбинированная терапия, предназначенная для лечения диабета и связанных с ним состояний
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
KR20110103968A (ko) 2008-12-23 2011-09-21 베링거 인겔하임 인터내셔날 게엠베하 유기 화합물의 염 형태
TW201036975A (en) 2009-01-07 2010-10-16 Boehringer Ingelheim Int Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy
MX364651B (es) 2009-11-27 2019-05-03 Boehringer Ingelheim Int Gmbh Star Inhibidores de dpp-iv, tales como la linagliptina, y composiciones farmacéuticas o combinaciones que comprenden los mismos, para usarse en el tratamiento de pacientes diabéticos tipificados genéticamente.
EP2566469B1 (de) 2010-05-05 2022-12-21 Boehringer Ingelheim International GmbH Kombinationstherapie
EP2585101A1 (de) 2010-06-24 2013-05-01 Boehringer Ingelheim International GmbH Diabetestherapie
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
MX366629B (es) 2011-07-15 2019-07-17 Boehringer Ingelheim Int Quinazolinas sustituidas, su preparación y su uso en composiciones farmacéuticas.
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
EP3685839A1 (de) 2012-05-14 2020-07-29 Boehringer Ingelheim International GmbH Linagliptin zur verwendung in der behandlung von albuminuria und nierenbedingten erkrankungen
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
CN102924339B (zh) * 2012-11-23 2014-06-04 温州澳珀化工有限公司 一种制备米托胍腙的方法
EP3110449B1 (de) 2014-02-28 2023-06-28 Boehringer Ingelheim International GmbH Medizinische verwendung eines dpp-4-inhibitors
JP5975369B2 (ja) 2014-06-10 2016-08-23 三菱瓦斯化学株式会社 ゴム変性用組成物及びその製造方法、タイヤ用変性ゴム、タイヤ用ゴム組成物並びにタイヤ
WO2017211979A1 (en) 2016-06-10 2017-12-14 Boehringer Ingelheim International Gmbh Combinations of linagliptin and metformin
FR3112428A1 (fr) 2020-07-13 2022-01-14 Semco Smartech France Procédé de formation de contacts passivés pour cellules solaires IBC

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2584784A (en) * 1949-05-21 1952-02-05 Du Pont Salts of 1-salicylalaminoguanidine
FR1013816A (fr) * 1949-05-24 1952-08-05 Wander Ag Dr A Procédé pour la préparation de p-uréidobenzalthio-semicarbazones substituées
CH383948A (de) * 1959-07-22 1964-11-15 Ciba Geigy Verfahren zur Herstellung neuer Hydrazone
FR1332543A (fr) * 1962-01-09 1963-07-19 Ciba Geigy Nouvelles hydrazones et leur procédé de préparation

Also Published As

Publication number Publication date
AT291283B (de) 1971-07-12
FR2007382B1 (de) 1974-02-01
NL6905258A (de) 1969-10-07
IE33021L (en) 1969-10-04
FR2007382A1 (de) 1970-01-09
SE343574B (de) 1972-03-13
US3673241A (en) 1972-06-27
DE1914999A1 (de) 1969-11-06
IE33021B1 (en) 1974-02-20
GB1241130A (en) 1971-07-28
BE731015A (de) 1969-10-03

Similar Documents

Publication Publication Date Title
AT297731B (de) Verfahren zur Herstellung von neuen Guanylhydrazonen und ihren Salzen
AT299193B (de) Verfahren zur Herstellung von neuen Imidazolidinochinalinderivaten und ihren Salzen
AT285599B (de) Verfahren zur Herstellung von neuen trisubstituierten 2-Arylaminoimidazolinen und ihren Salzen
AT310729B (de) Verfahren zur Herstellung von neuen Aminophenyl-cycloamidinen und ihren Salzen
AT301524B (de) Verfahren zur Herstellung von neuen β-Amino-β-hydroxyphenylalkancarbonsäuren und ihren Salzen
AT287694B (de) Verfahren zur Herstellung von neuen Imidazolindinderivaten und ihren Salzen
AT292010B (de) Verfahren zur Herstellung von neuen Aminoguanidin-Derivaten und ihren Salzen
AT297727B (de) Verfahren zur Herstellung von neuen 3-Aryl-benzazinen und ihren Salzen
AT289808B (de) Verfahren zur Herstellung von neuen Tetrahydropyrimidinen und ihren Salzen
AT306741B (de) Verfahren zur Herstellung von neuen 3-Guanidinoalkyl-thiophenen und ihren Salzen
AT286278B (de) Verfahren zur Herstellung von neuen 2-Phenylimino-pyrrolidinen und ihren Salzen
AT287699B (de) Verfahren zur Herstellung von neuen Imidazolidinderivaten und ihren Salzen
AT287695B (de) Verfahren zur Herstellung von neuen Imidazolidinderivaten und ihren Salzen
AT280267B (de) Verfahren zur Herstellung von neuen 2-Iminomethyleniminen und ihren Salzen
AT306008B (de) Verfahren zur Herstellung von neuen 2-Arylimino-thiazolidinen und ihren Salzen
AT289816B (de) Verfahren zur Herstellung von neuen Benzoxazepinonen und ihren Salzen
AT283323B (de) Verfahren zur herstellung von neuen aminoketonen und ihren salzen
AT283325B (de) Verfahren zur herstellung von neuen aminoketonen und ihren salzen
AT291279B (de) Verfahren zur Herstellung von neuen Benzolsulfonylharnstoffderivaten und ihren Salzen
AT288373B (de) Verfahren zur Herstellung von neuen Imidazolidinderivaten und ihren Salzen
AT288377B (de) Verfahren zur Herstellung von neuen Imidazolidinderivaten und ihren Salzen
AT288376B (de) Verfahren zur Herstellung von neuen Imidazolidinderivaten und ihren Salzen
AT309700B (de) Verfahren zur Herstellung von neuen 2-Benzoylalbenzomorphanen und ihren Salzen
AT289793B (de) Verfahren zur Herstellung von neuen Tetrazolderivaten und ihren Salzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee